{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-039016","form_type":"8-K","ticker":"BCTX","cik":"0001610820","company_name":"BriaCell Therapeutics Corp.","filed_at":"2024-10-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.977544+00:00","generated_at":"2026-05-30T23:27:42.729080+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"BriaCell: 100% resolution of temporal lobe brain metastasis in heavily pre-treated breast cancer patient","bullets":["Patient with 'eye-bulging' orbital tumor and brain metastasis achieved complete resolution of temporal lobe lesion at 8 and 11 months on Bria-IMT plus checkpoint inhibitor.","Heavily pre-treated patient had failed 8 prior regimens including ADC therapy; continues treatment after 17 cycles and 12 months on study.","Orbital tumor showed near-complete resolution; tumor markers (blood tests) sustained drop confirming imaging results.","CEO cites unprecedented potential in metastatic breast cancer brain metastasis; Phase 3 study evaluating brain metastasis subgroup ongoing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-039016","json":"https://secwatch.observer/filing/0001493152-24-039016.json","markdown":"https://secwatch.observer/filing/0001493152-24-039016.md","text":"https://secwatch.observer/filing/0001493152-24-039016.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1610820/000149315224039016/0001493152-24-039016-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1610820/000149315224039016/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T23:27:42.729080+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}